COVID-19 associated Kikuchi-Fujimoto disease.
作者信息
Stimson Laura, Stitson Richard, Bahhadi-Hardo Maria, Renaudon-Smith Edward
机构信息
Frimley Health NHS Foundation Trust, Surrey, UK.
出版信息
Br J Haematol. 2021 Mar;192(5):e124-e126. doi: 10.1111/bjh.17292. Epub 2021 Feb 7.
Abstract
摘要
相似文献
1
COVID-19 associated Kikuchi-Fujimoto disease.
Br J Haematol. 2021 Mar;192(5):e124-e126. doi: 10.1111/bjh.17292. Epub 2021 Feb 7.
2
The histiocytic component of cutaneous manifestations of Kikuchi disease expresses myeloperoxidase.
Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):202-3. doi: 10.1097/PAI.0b013e318074c94c.
3
[The diagnosis and differential diagnosis of histiocytic necrotizing lymphadenitis. A study of histology, immunohistochemistry and electron microscopy].
Zhonghua Bing Li Xue Za Zhi. 2003 Dec;32(6):525-9.
4
[Successful management of Kikuchi-Fujimoto disease caused by SARS-CoV-2].
Orv Hetil. 2022 Jul 3;163(27):1061-1065. doi: 10.1556/650.2022.32559.
5
[An "exotic" lymphadenopathy: Kikuchi-Fujimotor histiocytic necrotizing lymphadenitis. Case report and discussion].
Praxis (Bern 1994). 2000 Apr 13;89(16):671-4.
6
Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report.
BMC Infect Dis. 2021 Aug 3;21(1):740. doi: 10.1186/s12879-021-06048-0.
7
Histiocytic necrotizing lymphadenitis without granulocytic infiltration (the so called Kikuchi-Fujimoto disease).
Pol J Pathol. 2008;59(1):55-61.
8
Kikuchi-Fujimoto disease: case report.
Pol Arch Med Wewn. 2009 Dec;119(12):826-9.
9
Kikuchi-Fujimoto disease associated with systemic lupus erythematosus.
J Clin Rheumatol. 2005 Dec;11(6):341-2. doi: 10.1097/01.rhu.0000191539.52897.ee.
10
Kikuchi-Fujimoto disease.
Arch Pathol Lab Med. 2010 Feb;134(2):289-93. doi: 10.5858/134.2.289.
引用本文的文献
1
Kikuchi-Fujimoto Disease: A Rare Condition Mimicking Sepsis.
Iran J Otorhinolaryngol. 2025;37(3):161-164. doi: 10.22038/ijorl.2025.82006.3754.
2
Perforin-2 is overexpressed in Kikuchi-Fujimoto disease.
Virchows Arch. 2025 Feb 7. doi: 10.1007/s00428-025-04046-0.
3
Kikuchi-Fujimoto disease following SARS-CoV-2 infection: A rare disease with increased incidence during the COVID-19 pandemic?
Respirol Case Rep. 2024 Jun 19;12(6):e01414. doi: 10.1002/rcr2.1414. eCollection 2024 Jun.
4
COVID-19 vaccine-associated lymphadenopathy: a review.
Infez Med. 2024 Jun 1;32(2):119-130. doi: 10.53854/liim-3202-1. eCollection 2024.
5
A Case Report: Kikuchi Disease Associated With a Positive Auto-Immune Panel Triggered by COVID-19 Infection.
Cureus. 2023 Dec 21;15(12):e50911. doi: 10.7759/cureus.50911. eCollection 2023 Dec.
6
Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.
Rev Esp Patol. 2024 Jan-Mar;57(1):42-47. doi: 10.1016/j.patol.2023.01.002. Epub 2023 Feb 28.
7
Kikuchi-Fujimoto disease following COVID-19 in a 32-year-old woman.
J Clin Exp Hematop. 2023 Sep 28;63(3):209-211. doi: 10.3960/jslrt.23022. Epub 2023 Jul 28.
8
Kikuchi-Fujimoto disease: A comprehensive review.
World J Clin Cases. 2023 Jun 6;11(16):3664-3679. doi: 10.12998/wjcc.v11.i16.3664.
9
Kikuchi-Fujimoto Disease: A Case of SARS-CoV-2 Infection Triggering the Rare Disease.
Cureus. 2023 Mar 7;15(3):e35858. doi: 10.7759/cureus.35858. eCollection 2023 Mar.
10
Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management.
BMJ Case Rep. 2022 Dec 30;15(12):e252030. doi: 10.1136/bcr-2022-252030.
本文引用的文献
1
COVID-19 and multisystem inflammatory syndrome in children and adolescents.
Lancet Infect Dis. 2020 Nov;20(11):e276-e288. doi: 10.1016/S1473-3099(20)30651-4. Epub 2020 Aug 17.
2
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Clin Rheumatol. 2020 Jul;39(7):2085-2094. doi: 10.1007/s10067-020-05190-5. Epub 2020 May 30.
3
Fatal Kikuchi-like lymphadenitis associated with connective tissue disease: a report of two cases and review of the literature.
Springerplus. 2015 Apr 8;4:167. doi: 10.1186/s40064-015-0925-7. eCollection 2015.
4
Diagnostic dilemma: Kikuchi's disease or tuberculosis?
BMJ Case Rep. 2013 Jan 29;2013:bcr2012008026. doi: 10.1136/bcr-2012-008026.
5
Kikuchi-fujimoto disease: a case report and literature review.
Case Rep Otolaryngol. 2012;2012:497604. doi: 10.1155/2012/497604. Epub 2012 Jul 26.
6
Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype.
Am J Clin Pathol. 2009 Feb;131(2):174-82. doi: 10.1309/AJCP7V1QHJLOTKKJ.
7
Enigmatic Kikuchi-Fujimoto disease: a comprehensive review.
Am J Clin Pathol. 2004 Jul;122(1):141-52. doi: 10.1309/YF08-1L4T-KYWV-YVPQ.
8
CT findings in Kikuchi disease: analysis of 96 cases.
AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1099-102.
9
Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy.
Am J Pathol. 2001 Sep;159(3):915-24. doi: 10.1016/S0002-9440(10)61767-1.
10
DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi's disease).
Tissue Antigens. 1999 Sep;54(3):246-53. doi: 10.1034/j.1399-0039.1999.540305.x.
Zotero 插件